These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30181547)

  • 21. Role of Dicer1 in thyroid cell proliferation and differentiation.
    Penha RCC; Sepe R; De Martino M; Esposito F; Pellecchia S; Raia M; Del Vecchio L; Decaussin-Petrucci M; De Vita G; Pinto LFR; Fusco A
    Cell Cycle; 2017; 16(23):2282-2289. PubMed ID: 28933615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress.
    Song H; Chen X; Jiao Q; Qiu Z; Shen C; Zhang G; Sun Z; Zhang H; Luo QY
    Thyroid; 2021 Feb; 31(2):233-246. PubMed ID: 32772829
    [No Abstract]   [Full Text] [Related]  

  • 23. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection.
    Onder S; Mete O; Yilmaz I; Bayram A; Bagbudar S; Altay AY; Issin G; Terzi NK; Iscan Y; Sormaz IC; Tunca F; Senyurek YG; Yegen G
    Endocr Pathol; 2022 Dec; 33(4):437-445. PubMed ID: 36251117
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ricarte-Filho JC; Casado-Medrano V; Reichenberger E; Spangler Z; Scheerer M; Isaza A; Baran J; Patel T; MacFarland SP; Brodeur GM; Stewart DR; Baloch Z; Bauer AJ; Wasserman JD; Franco AT
    Front Endocrinol (Lausanne); 2023; 14():1083382. PubMed ID: 36896180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China.
    Huang M; Yan C; Xiao J; Wang T; Ling R
    Diagn Pathol; 2019 Jul; 14(1):74. PubMed ID: 31300059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations.
    Oishi N; Vuong HG; Mochizuki K; Kondo T
    Endocr Pathol; 2020 Dec; 31(4):359-366. PubMed ID: 33058026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
    Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
    Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower
    Meng Z; Matsuse M; Saenko V; Yamashita S; Ren P; Zheng X; Jia Q; Tan J; Li N; Zheng W; Zhao L; Mitsutake N
    IUBMB Life; 2019 Jul; 71(7):1030-1040. PubMed ID: 31026111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation and Hypermethylation of GABPB1 Is Associated with Aggressive Thyroid Cancer Features.
    Xing X; Mu N; Yuan X; Wang N; Juhlin CC; Strååt K; Larsson C; Neo SY; Xu D
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between Genetic Polymorphisms in microRNA Machinery Genes and Risk of Papillary Thyroid Carcinoma.
    Mohammadpour-Gharehbagh A; Heidari Z; Eskandari M; Aryan A; Salimi S
    Pathol Oncol Res; 2020 Apr; 26(2):1235-1241. PubMed ID: 31250375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation.
    Chien MN; Yang PS; Hsu YC; Liu TP; Lee JJ; Cheng SP
    Head Neck; 2018 Nov; 40(11):2528-2537. PubMed ID: 30102829
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Mastnikova K; Bulanova Pekova B; Kuklikova V; Vaclavikova E; Carkova J; Katra R; Fialova L; Vlcek P; Kodetova D; Chovanec M; Drozenova J; Matej R; Pacesova P; Novak Z; Procykova K; Vcelak J; Bendlova B
    Thyroid; 2024 Oct; 34(10):1225-1233. PubMed ID: 39283830
    [No Abstract]   [Full Text] [Related]  

  • 33. TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.
    Min J; Shay JW
    Cancer Discov; 2016 Nov; 6(11):1212-1214. PubMed ID: 27807101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three synchronous malignancies in a patient with DICER1 syndrome.
    Moke DJ; Thomas SM; Hiemenz MC; Nael A; Wang K; Shillingford N; Biegel JA; Mascarenhas L
    Eur J Cancer; 2018 Apr; 93():140-143. PubMed ID: 29395683
    [No Abstract]   [Full Text] [Related]  

  • 35. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
    Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
    Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DICER1 Mutations and Differentiated Thyroid Carcinoma: Evidence of a Direct Association.
    Rutter MM; Jha P; Schultz KA; Sheil A; Harris AK; Bauer AJ; Field AL; Geller J; Hill DA
    J Clin Endocrinol Metab; 2016 Jan; 101(1):1-5. PubMed ID: 26555935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [
    Yang T; Chen C; Pan NF; Sun LY; Jiang XL; Li JN; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):919-924. PubMed ID: 31880125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
    Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
    Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired microRNA processing by DICER1 downregulation endows thyroid cancer with increased aggressiveness.
    Ramírez-Moya J; Wert-Lamas L; Riesco-Eizaguirre G; Santisteban P
    Oncogene; 2019 Jul; 38(27):5486-5499. PubMed ID: 30967628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SLC6A15 acts as a tumor suppressor to inhibit migration and invasion in human papillary thyroid cancer.
    Chen Y; Li H; Liang W; Guo Y; Peng M; Ke W; Xiao H; Guan H; Li Y
    J Cell Biochem; 2021 Aug; 122(8):814-826. PubMed ID: 33690923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.